171 related articles for article (PubMed ID: 11511718)
1. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100.
Agelink MW; Andrich J; Postert T; Würzinger U; Zeit T; Klotz P; Przuntek H
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):394-6. PubMed ID: 11511718
[TBL] [Abstract][Full Text] [Related]
2. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein.
Palmio J; Huuhka M; Laine S; Huhtala H; Peltola J; Leinonen E; Suhonen J; Keränen T
Psychiatry Res; 2010 May; 177(1-2):97-100. PubMed ID: 20378182
[TBL] [Abstract][Full Text] [Related]
3. Serum neuron-specific enolase levels do not increase after electroconvulsive therapy.
Berrouschot J; Rolle K; Kühn HJ; Schneider D
J Neurol Sci; 1997 Sep; 150(2):173-6. PubMed ID: 9268247
[TBL] [Abstract][Full Text] [Related]
4. Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression.
Kranaster L; Janke C; Mindt S; Neumaier M; Sartorius A
J Neural Transm (Vienna); 2014 Nov; 121(11):1411-5. PubMed ID: 24801966
[TBL] [Abstract][Full Text] [Related]
5. A new early cognitive screening measure to detect cognitive side-effects of electroconvulsive therapy?
Martin DM; Katalinic N; Ingram A; Schweitzer I; Smith DJ; Hadzi-Pavlovic D; Loo CK
J Psychiatr Res; 2013 Dec; 47(12):1967-74. PubMed ID: 24074514
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Practice of Assessing Cognitive Function in Adults Receiving Electroconvulsive Therapy: Whom Are We Missing?
Obbels J; Vanbrabant K; Bouckaert F; Verwijk E; Sienaert P
J ECT; 2016 Jun; 32(2):99-103. PubMed ID: 26421675
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.
Verwijk E; Comijs HC; Kok RM; Spaans HP; Tielkes CE; Scherder EJ; Stek ML
Int Psychogeriatr; 2014 Feb; 26(2):315-24. PubMed ID: 24280446
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of s-100 protein and neuron-specific enolase as serum markers for cerebral deficiency after general anesthesia. Study in patient with hip or knee replacement].
Linstedt U; Kropp P; Möller C; Zenz M
Anaesthesist; 2000 Oct; 49(10):887-92. PubMed ID: 11100253
[TBL] [Abstract][Full Text] [Related]
10. Maintenance electroconvulsive therapy up to 12 years.
Elias A; Chathanchirayil SJ; Bhat R; Prudic J
J Affect Disord; 2014 Mar; 156():228-31. PubMed ID: 24355648
[TBL] [Abstract][Full Text] [Related]
11. Effects of maintenance electroconvulsive therapy on cognitive functions.
Vothknecht S; Kho KH; van Schaick HW; Zwinderman AH; Middelkoop H; Blansjaar BA
J ECT; 2003 Sep; 19(3):151-7. PubMed ID: 12972985
[TBL] [Abstract][Full Text] [Related]
12. Correlation among decreased regional cerebral oxygen saturation, blood levels of brain injury biomarkers, and cognitive disorder.
Kumpaitiene B; Svagzdiene M; Drigotiene I; Sirvinskas E; Sepetiene R; Zakelis R; Benetis R
J Int Med Res; 2018 Sep; 46(9):3621-3629. PubMed ID: 29896989
[TBL] [Abstract][Full Text] [Related]
13. Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility.
Pelsers MM; Hanhoff T; Van der Voort D; Arts B; Peters M; Ponds R; Honig A; Rudzinski W; Spener F; de Kruijk JR; Twijnstra A; Hermens WT; Menheere PP; Glatz JF
Clin Chem; 2004 Sep; 50(9):1568-75. PubMed ID: 15217991
[TBL] [Abstract][Full Text] [Related]
14. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
Pleines UE; Morganti-Kossmann MC; Rancan M; Joller H; Trentz O; Kossmann T
J Neurotrauma; 2001 May; 18(5):491-8. PubMed ID: 11393252
[TBL] [Abstract][Full Text] [Related]
15. Do blood levels of neuron-specific enolase and S-100 protein reflect cognitive dysfunction after coronary artery bypass?
Rasmussen LS; Christiansen M; Hansen PB; Moller JT
Acta Anaesthesiol Scand; 1999 May; 43(5):495-500. PubMed ID: 10341995
[TBL] [Abstract][Full Text] [Related]
16. Patient, treatment, and anatomical predictors of outcome in electroconvulsive therapy: a prospective study.
van Waarde JA; van Oudheusden LJ; Heslinga OB; Verwey B; van der Mast RC; Giltay E
J ECT; 2013 Jun; 29(2):113-21. PubMed ID: 23475028
[TBL] [Abstract][Full Text] [Related]
17. Detecting objective and subjective cognitive effects of electroconvulsive therapy: intensity, duration and test utility in a large clinical sample.
Fernie G; Bennett DM; Currie J; Perrin JS; Reid IC
Psychol Med; 2014 Oct; 44(14):2985-94. PubMed ID: 25065412
[TBL] [Abstract][Full Text] [Related]
18. Decreased Cognitive Functioning After Electroconvulsive Therapy Is Related to Increased Hippocampal Volume: Exploring the Role of Brain Plasticity.
van Oostrom I; van Eijndhoven P; Butterbrod E; van Beek MH; Janzing J; Donders R; Schene A; Tendolkar I
J ECT; 2018 Jun; 34(2):117-123. PubMed ID: 29389676
[TBL] [Abstract][Full Text] [Related]
19. Immediate and long-term effects of bilateral electroconvulsive therapy on cognitive functioning in patients with a depressive disorder.
Nuninga JO; Claessens TFI; Somers M; Mandl R; Nieuwdorp W; Boks MP; Bakker S; Begemann MJH; Heringa S; Sommer IEC
J Affect Disord; 2018 Oct; 238():659-665. PubMed ID: 29966930
[TBL] [Abstract][Full Text] [Related]
20. Concomitant Anticonvulsants With Bitemporal Electroconvulsive Therapy: A Randomized Controlled Trial With Clinical and Neurobiological Application.
Rakesh G; Thirthalli J; Kumar CN; Muralidharan K; Phutane VH; Gangadhar BN
J ECT; 2017 Mar; 33(1):16-21. PubMed ID: 27668943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
